173 related articles for article (PubMed ID: 14976040)
1. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.
Rimsza LM; Roberts RA; Miller TP; Unger JM; LeBlanc M; Braziel RM; Weisenberger DD; Chan WC; Muller-Hermelink HK; Jaffe ES; Gascoyne RD; Campo E; Fuchs DA; Spier CM; Fisher RI; Delabie J; Rosenwald A; Staudt LM; Grogan TM
Blood; 2004 Jun; 103(11):4251-8. PubMed ID: 14976040
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas.
Dersh D; Phelan JD; Gumina ME; Wang B; Arbuckle JH; Holly J; Kishton RJ; Markowitz TE; Seedhom MO; Fridlyand N; Wright GW; Huang DW; Ceribelli M; Thomas CJ; Lack JB; Restifo NP; Kristie TM; Staudt LM; Yewdell JW
Immunity; 2021 Jan; 54(1):116-131.e10. PubMed ID: 33271120
[TBL] [Abstract][Full Text] [Related]
3. Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.
Challa-Malladi M; Lieu YK; Califano O; Holmes AB; Bhagat G; Murty VV; Dominguez-Sola D; Pasqualucci L; Dalla-Favera R
Cancer Cell; 2011 Dec; 20(6):728-40. PubMed ID: 22137796
[TBL] [Abstract][Full Text] [Related]
4. The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.
Ruminy P; Etancelin P; Couronné L; Parmentier F; Rainville V; Mareschal S; Bohers E; Burgot C; Cornic M; Bertrand P; Lenormand B; Picquenot JM; Jardin F; Tilly H; Bastard C
Leukemia; 2011 Apr; 25(4):681-8. PubMed ID: 21233831
[TBL] [Abstract][Full Text] [Related]
5. The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses.
Aptsiauri N; Ruiz-Cabello F; Garrido F
Curr Opin Immunol; 2018 Apr; 51():123-132. PubMed ID: 29567511
[TBL] [Abstract][Full Text] [Related]
6. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.
Toffalori C; Zito L; Gambacorta V; Riba M; Oliveira G; Bucci G; Barcella M; Spinelli O; Greco R; Crucitti L; Cieri N; Noviello M; Manfredi F; Montaldo E; Ostuni R; Naldini MM; Gentner B; Waterhouse M; Zeiser R; Finke J; Hanoun M; Beelen DW; Gojo I; Luznik L; Onozawa M; Teshima T; Devillier R; Blaise D; Halkes CJM; Griffioen M; Carrabba MG; Bernardi M; Peccatori J; Barlassina C; Stupka E; Lazarevic D; Tonon G; Rambaldi A; Cittaro D; Bonini C; Fleischhauer K; Ciceri F; Vago L
Nat Med; 2019 Apr; 25(4):603-611. PubMed ID: 30911134
[TBL] [Abstract][Full Text] [Related]
7. Immune Escape of Relapsed AML Cells after Allogeneic Transplantation.
Christopher MJ; Petti AA; Rettig MP; Miller CA; Chendamarai E; Duncavage EJ; Klco JM; Helton NM; O'Laughlin M; Fronick CC; Fulton RS; Wilson RK; Wartman LD; Welch JS; Heath SE; Baty JD; Payton JE; Graubert TA; Link DC; Walter MJ; Westervelt P; Ley TJ; DiPersio JF
N Engl J Med; 2018 Dec; 379(24):2330-2341. PubMed ID: 30380364
[TBL] [Abstract][Full Text] [Related]
8. Complex associations between cancer progression and immune gene expression reveals early influence of transmissible cancer on Tasmanian devils.
Raven N; Klaassen M; Madsen T; Jones M; Hamilton DG; Ruiz-Aravena M; Thomas F; Hamede RK; Ujvari B
Front Immunol; 2024; 15():1286352. PubMed ID: 38515744
[TBL] [Abstract][Full Text] [Related]
9. Metabolic instruction of the graft-versus-leukemia immunity.
Burk AC; Apostolova P
Front Immunol; 2024; 15():1347492. PubMed ID: 38500877
[TBL] [Abstract][Full Text] [Related]
10. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
Eriksen PRG; de Groot F; Clasen-Linde E; de Nully Brown P; de Groen R; Melchior LC; Maier AD; Minderman M; Vermaat JSP; von Buchwald C; Pals ST; Heegaard S
Blood Adv; 2024 Apr; 8(8):1946-1957. PubMed ID: 38324724
[TBL] [Abstract][Full Text] [Related]
11. Emerging Therapeutic Targets and Drug Resistance Mechanisms in Immunotherapy of Hematological Malignancies.
Olejarz W; Basak G
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136311
[TBL] [Abstract][Full Text] [Related]
12. Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program.
Weiss J; Gibbons K; Ehyaee V; Perez-Silos V; Zevallos A; Maienschein-Cline M; Brister E; Sverdlov M; Shah E; Balakrishna J; Symes E; Frederiksen JK; Gann PH; Post R; Lopez-Hisijos N; Reneau J; Venkataraman G; Bailey N; Brown NA; Xu ML; Wilcox RA; Inamdar K; Murga-Zamalloa C
Am J Pathol; 2024 Jan; 194(1):165-178. PubMed ID: 37923249
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the aberrant immunophenotype and clinical characteristics in dogs with lymphoma: a study of 27 cases.
Bae H; Kim SK; Yu D
Front Vet Sci; 2023; 10():1254458. PubMed ID: 37908841
[TBL] [Abstract][Full Text] [Related]
14. Differential molecular programs of cutaneous anaplastic large cell lymphoma and CD30-positive transformed mycosis fungoides.
Lai P; Liu F; Liu X; Sun J; Wang Y
Front Immunol; 2023; 14():1270365. PubMed ID: 37790936
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic analysis of stem cells from chorionic villi uncovers the impact of chromosomes 2, 6 and 22 in the clinical manifestations of Down syndrome.
Vaiasicca S; Melone G; James DW; Quintela M; Preziuso A; Finnell RH; Conlan RS; Francis LW; Corradetti B
Stem Cell Res Ther; 2023 Sep; 14(1):265. PubMed ID: 37740230
[TBL] [Abstract][Full Text] [Related]
16. Novel Functional Features of cGMP Substrate Proteins IRAG1 and IRAG2.
Prüschenk S; Majer M; Schlossmann J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372987
[TBL] [Abstract][Full Text] [Related]
17. Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma.
Song JY; Nwangwu M; He TF; Zhang W; Meawad H; Bedell V; Murata-Collins J; Skrabek P; Nasr MR; Scott D; Godfrey J; Lee P; Chan WC; Weisenburger DD; Perry AM; Herrera AF
Haematologica; 2023 Aug; 108(8):2167-2177. PubMed ID: 36632739
[TBL] [Abstract][Full Text] [Related]
18. Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors.
Cariello M; Squilla A; Piacente M; Venutolo G; Fasano A
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615316
[TBL] [Abstract][Full Text] [Related]
19. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.
Mangolini M; Maiques-Diaz A; Charalampopoulou S; Gerhard-Hartmann E; Bloehdorn J; Moore A; Giachetti G; Lu J; Roamio Franklin VN; Chilamakuri CSR; Moutsopoulos I; Rosenwald A; Stilgenbauer S; Zenz T; Mohorianu I; D'Santos C; Deaglio S; Hodson DJ; Martin-Subero JI; Ringshausen I
Nat Commun; 2022 Oct; 13(1):6220. PubMed ID: 36266281
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses.
Chan KL; Gomez J; Cardinez C; Kumari N; Sparbier CE; Lam EYN; Yeung MM; Garciaz S; Kuzich JA; Ong DM; Brown FC; Chan YC; Vassiliadis D; Wainwright EN; Motazedian A; Gillespie A; Fennell KA; Lai J; House IG; Macpherson L; Ang CS; Dawson SJ; Beavis PA; Wei AH; Burr ML; Dawson MA
Cancer Cell; 2022 Oct; 40(10):1190-1206.e9. PubMed ID: 36179686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
